BPC-157 in Australia, what the lab data actually shows
BPC-157 is one of the most-searched peptides in Australia and one of the most variably produced. This guide cuts through marketing claims with what independent CoA data shows about the AU market specifically.
What BPC-157 is
BPC-157 ("Body Protection Compound") is a synthetic 15-amino-acid peptide derived from a sequence isolated in human gastric juice. It's been studied primarily in animal models for tissue repair, gut healing, and tendon/ligament recovery endpoints.
Important: there are no completed phase 3 human trials of BPC-157 at time of writing. Marketing claims that present animal results as established human outcomes are misleading.
Legal status in Australia
BPC-157 is a Schedule 4 prescription-only substance in Australia. It is also on the WADA Prohibited List for athletes. Legal supply requires a prescription from an Australian-registered prescriber. See our Australian peptide legal guide for the full picture.
What the Australian market looks like
BPC-157 is one of the more consistent peptides to manufacture, but the Australian market is small and fragmented. Independent CoAs collected on LabDoc show:
Purity is usually high: most domestic vendors test in the 97-99% HPLC range when they actually have third-party data.
Peptide content varies: vials labelled 5mg sometimes test at 3.5-4mg of actual peptide. Always cross-check quantitative HPLC.
Many vendors have no third-party data at all, relying instead on in-house QA reports or supplier-provided documents.
See the live BPC-157 lab results page for the current dataset across Australian and global vendors.
BPC-157 vs TB-500: why people compare them
Both are studied for connective-tissue and recovery endpoints, but the mechanisms are different. TB-500 (a fragment of thymosin beta-4) acts primarily on actin sequestration and cell migration; BPC-157 has a broader, less well-characterised mechanism touching nitric oxide pathways and growth factor expression. They are not substitutes, and combining them without medical oversight has no quality human trial data behind it.
How to vet a BPC-157 vendor
Ask for a batch CoA: third-party lab, recent date, identity confirmed.
Check the peptide content number, not just purity.
Look the vendor up on LabDoc Results filtered to BPC-157.
If the vendor is on LabDoc Verified, they've committed to ongoing independent testing.
Frequently asked questions
Is there human trial data for BPC-157?
No completed phase 3 human trials exist at the time of writing. The bulk of published BPC-157 data is animal-model research; marketing that presents this as established human efficacy is misleading.
What purity should BPC-157 test at?
Reputable BPC-157 typically tests at 97-99% HPLC purity. Anything under 95% should be treated as suspect, and peptide content (mg per vial) matters as much as purity.
Is BPC-157 legal in Australia?
BPC-157 is Schedule 4 prescription-only in Australia and is on the WADA Prohibited List. Legal supply requires a prescription from an Australian-registered prescriber.
Where can I see Australian BPC-157 lab results?
The BPC-157 profile page on LabDoc aggregates independent CoAs from Australian and global vendors with HPLC purity, identity, and batch-level traceability.